Loratidine improves ischemic parameters of exercise stress test in patients with acute myocardial infarction
Küçük Resim Yok
Tarih
2004
Yazarlar
Dergi Başlığı
Dergi ISSN
Cilt Başlığı
Yayıncı
Mosby, Inc
Erişim Hakkı
info:eu-repo/semantics/closedAccess
Özet
Background: This study sought to determine whether adding an anti-histaminic medication, loratidine, to anti-ischemic treatment would ameliorate or improve ischemic parameters induced by exercise stress test in patients who suffered an acute myocardial infarction. Methods: Twenty stable patients with acute inferior myocardial infarction who had a positive EST were randomly allocated into 2 groups, A and B. Patients in group A and B received a 10 mg loratidine tablet added daily to their anti-ischemic regimen for 7 days during the second and third week post-event, respectively. As the end of each period they underwent an exercise stress test (EST). Exercise parameters in each group were then compared before and after loratidine therapy. Results: Both groups showed improvements in exercise parameters after loratidine therapy compared to a basal EST results. STmax (group A: 1.9+/-0.74 vs 0.9+/-1.29 mm, P=.046, group B: 2.5+/-0,7 1 vs 1.4+/-1.17 mm, P=.041), STlead (group A: 3.4+/-1.08 vs 1.5+/- 2.12, P=.027;group B: 4.6+/-1.71 vs 2.22+/- 2.25, P=.011, STlead group A: 4.7 +/-2.18 vs 2.1+/-3.11 mm, P=.024; group B: 7.9+/-2.92 vs 3.33+/-3.81 mm, P =.005). Conclusion: Our study revealed that loratidine, a histamine-1 receptor blocker, improves ischemic parameters of EST when given as additive therapy to a routine anti-ischemic regimen during the sub-acute phase of myocardial infarction.
Açıklama
Anahtar Kelimeler
Immunoglobulin-E Response, Coronary-Arteries, Mast-Cells, Mechanism, Rupture, Erosion, Angina, Spasm, Site
Kaynak
American Heart Journal
WoS Q Değeri
Q1
Scopus Q Değeri
Q1
Cilt
148
Sayı
6
